Startup India Government of India
Aclima Therapeutics Derive Private Limited
Aclima Therapeutics Derive Private Limited - pharma in Greater Noida, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹57.18 Lakh
▼ 62% YoY
Net profit · FY 2025
₹3,352
Net margin 0.1%
EBITDA · FY 2025
₹4.2 Lakh
EBITDA margin 7.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Aclima Therapeutics Derive Private Limited
Data last updated:
Aclima Therapeutics Derive Private Limited is a private limited company based in Greater Noida, Uttar Pradesh, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51909UP2017PTC097522. Its GSTIN is 09AAQCA0992C1ZJ (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ashish Agrawal and Parul Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at L – 701 Plumeria Garden Estate Near Achhar Village Omicron – 3 Kasana, Greater Noida, Uttar Pradesh, India – 201310.
As per the financials filed for FY 2025, the company reported a revenue of ₹57.18 Lakh, a decline of 62% compared to the previous year. For the same year it recorded a net profit of ₹3,352 (net margin 0.1%) and EBITDA of ₹4.2 Lakh (EBITDA margin 7.4%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 6% over five years.
Aclima Therapeutics Derive Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0015315). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51909UP2017PTC097522
Registration Number 097522
Incorporation Date 04 October 2017
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-UP-28-0015315
Recognitions & Rankings of Aclima Therapeutics Derive
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-28-0015315
Contact details
Aclima Therapeutics Derive Private Limited's registered office is in Greater Noida, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressL – 701 Plumeria Garden Estate Near Achhar Village Omicron – 3 Kasana, Greater Noida, Uttar Pradesh, India – 201310
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Aclima Therapeutics Derive Private Limited, buy the company report.
Comprehensive company report
Aclima Therapeutics Derive Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Aclima Therapeutics Derive is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Aclima Therapeutics Derive Private Limited, buy the company report.
Financials of Aclima Therapeutics Derive Private Limited
FY 2024 filings availableAclima Therapeutics Derive Private Limited reported revenue of ₹57.18 Lakh (down 62% YoY) for FY 2025.
Revenue · FY 2025
₹57.18 Lakh ▼ 62%
Net profit · FY 2025
₹3,352 margin 0.1%
EBITDA · FY 2025
₹4.2 Lakh margin 7.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 62%
3 years · compounded
▼ 21%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▼ 46%
3 years · compounded
▲ 29%
5 years · compounded
▲ 46%
Revenue fell 62% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA fell 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.2 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3,352 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.4% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aclima Therapeutics Derive Private Limited, buy the company report.
Board of directors of Aclima Therapeutics Derive Private Limited
Aclima Therapeutics Derive has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashish Agrawal | Director | 02 Dec 2020 | 5 Years 10 Months | Current |
| Parul Agrawal | Director | 04 Oct 2017 | 9 Years 0 Months | Current |
| Ritie Aggrawal | Director | 29 May 2018 | 8 Years 4 Months | Current |
Auditor
Aclima Therapeutics Derive Private Limited is audited by AGARWAL & MALHOTRA for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGARWAL & MALHOTRA | FY 2023 | 012808C |
Shareholding
The shareholding of Aclima Therapeutics Derive Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aclima Therapeutics Derive Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aclima Therapeutics Derive Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aclima Therapeutics Derive Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aclima Therapeutics Derive has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAQCA0992C1ZJ | Uttar Pradesh | Active | 02 Nov 2017 |
To see the full GST registrations and return filing status of Aclima Therapeutics Derive Private Limited, buy the company report.
Recent activity
Aclima Therapeutics Derive Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Harish Agarwal Chandra ceased to be Director on 05 Aug 2021.
AGM
Aclima Therapeutics Derive Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Aclima Therapeutics Derive Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.
Ceased
Harish Agarwal Chandra ceased to be Director.
Appointed
Ashish Agrawal was appointed as Director.
Appointed
Ritie Aggrawal was appointed as Director.
Appointed
Parul Agrawal was appointed as Director.
Incorporation
04 Oct 2017
Aclima Therapeutics Derive Private Limited was registered on 04 Oct 2017 with Roc Kanpur & aged 9 years 18 days as per MCA records.
Frequently asked questions
Aclima Therapeutics Derive is an active private limited company based in Greater Noida, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 October 2017 (9+ years old) and is registered under CIN U51909UP2017PTC097522.
Aclima Therapeutics Derive has 3 current directors:
- Ashish Agrawal - Director
- Parul Agrawal - Director
- Ritie Aggrawal - Director
The latest financial statements of Aclima Therapeutics Derive on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Aclima Therapeutics Derive is 09AAQCA0992C1ZJ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Aclima Therapeutics Derive is U51909UP2017PTC097522. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aclima Therapeutics Derive was incorporated on 04 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kanpur.
Harish Agarwal Chandra ceased to be Director on 05 Aug 2021. Ashish Agrawal was appointed as Director on 02 Dec 2020. Ritie Aggrawal was appointed as Director on 29 May 2018. Aclima Therapeutics Derive has 4 board changes on record in total.
Yes, Aclima Therapeutics Derive is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Aclima Therapeutics Derive is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-28-0015315).
The registered office of Aclima Therapeutics Derive is at L – 701 Plumeria Garden Estate Near Achhar Village Omicron – 3 Kasana, Greater Noida, Uttar Pradesh, India – 201310.